Final ID: MP-17
Lu Xiaohan, Ren Jiafa, Wen Yi, Griffiths Robert, Yang Ting, Hammer Gianna, Zhuo Jia, Crowley Steven
Angiotensin II vascular abnormalities in 32.5% of 3322 patients with essential hypertension(EH): Use of angiotensin II analogue, saralasin.Anderson Gunnar